EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan

JOURNAL ARTICLE published 1 December 2008 in Journal of Clinical Oncology

Authors: Toshimi Takano | Tomoya Fukui | Yuichiro Ohe | Koji Tsuta | Seiichiro Yamamoto | Hiroshi Nokihara | Noboru Yamamoto | Ikuo Sekine | Hideo Kunitoh | Koh Furuta | Tomohide Tamura